Tanja Fangerau
Ulm, BW 89081, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
First multicenter real-world analysis of switching to next-generation enzyme replacement therapies in late-onset Pompe disease.
Journal: Journal of neurology
Published: November 19, 2025
Evaluating the short-term and long-term therapeutic effects of immunoadsorption compared with plasma exchange in chronic inflammatory demyelinating polyneuropathy: a long-term, prospective, observational study.
Journal: EClinicalMedicine
Published: September 18, 2025
Sensitivity and Specificity of a Revised Version of the TRACK-MS Screening Battery for Early Detection of Cognitive Impairment in Patients with Multiple Sclerosis.
Journal: Biomedicines
Published: July 09, 2025
Quality of Life in Multiple Sclerosis Compared to Amyotrophic Lateral Sclerosis: Fatigue and Fast Disease Progression Interferes with the Ability to Psychosocially Adjust.
Journal: Brain sciences
Published: June 23, 2025
Plasma Exchange vs. Immunoadsorption: Effects on Immunological Markers and Predictive Value in Steroid-Refractory MS Attacks.
Journal: Multiple sclerosis journal - experimental, translational and clinical
Published: September 17, 2024
Serum neurofilament light chain and glial fibrillary acidic protein for predicting response to apheresis in steroid-refractory multiple sclerosis relapses.
Journal: European journal of neurology
Published: February 29, 2024
Gadolinium contrast agents: dermal deposits and potential effects on epidermal small nerve fibers.
Journal: Journal of neurology
Published: December 28, 2022
Small fiber involvement is independent from clinical pain in late-onset Pompe disease.
Journal: Orphanet journal of rare diseases
Published: February 10, 2022
Exacerbation of chronic inflammatory demyelinating polyneuropathy in concomitance with COVID-19.
Journal: Journal of the neurological sciences
Published: July 15, 2020
Drug-induced liver injury associated with the biosimilar glatiramer acetate (Clift®).
Journal: Multiple sclerosis and related disorders
Published: November 17, 2019
Safety and efficacy of immunoadsorption versus plasma exchange in steroid-refractory relapse of multiple sclerosis and clinically isolated syndrome: A randomised, parallel-group, controlled trial.
Journal: EClinicalMedicine
Published: October 07, 2019
Last Updated: 09/26/2026